Press Release
March 25th, 2025
.png)
LMU Hospital and LARALAB Partner on Generative AI for Cardiac Treatments
MUNICH, GERMANY, March 19th, 2025 / LARALAB GmbH, a pioneer in AI-driven medical imaging, and LMU Hospital, one of Germany’s leading cardiovascular centers, have entered into a multi-year clinical partnership to advance Generative AI for the treatment of mitral regurgitation. The collaboration aims to improve patient outcomes by leveraging deep learning and state-of-the-art multimodal AI models to optimize transcatheter mitral valve edge-to-edge repair (M-TEER).
Developing Predictive AI for Mitral Valve Repair
The project aims to enhance patient outcomes by applying AI-driven analysis to improve decision-making in mitral regurgitation treatment. By integrating multimodal AI, the collaboration seeks to refine patient selection, predict procedural success, and optimize treatment strategies. Additionally, patients who may not benefit from M-TEER can be considered for alternative treatment options such as transcatheter mitral valve replacement (TMVR), expanding access to more effective therapies.
The research is based on an extensive, high-quality dataset, including pre- and post-interventional TEE echocardiographic data from the mitral valve, supporting a more standardized and objective approach to analyzing patient-specific anatomical characteristics.
“We see enormous potential in AI-based predictive modeling to refine patient selection and procedural strategies,” says Prof. Dr. med. Jörg Hausleiter, Head of the Mitral and Tricuspid Valve Program and Deputy Director at the LMU Hospital. “By collaborating with LARALAB, we aim to develop and validate new AI solutions using retrospective data in the first project phase, with the potential to progress into a prospective study.”
Prof. Dr. med. Jörg Hausleiter
Head of the Mitral and Tricuspid Valve Program and Deputy Director
LMU Hospital, Munich
A proof-of-concept prototype has already been successfully realized, demonstrating the feasibility of automated AI processing of transesophageal echocardiography (TEE) data for M-TEER. The project is supported by leading cardiac imaging and interventional experts at LMU Hospital and LARALAB’s AI research team, with funding from the Bavarian Research Foundation.
About LARALAB
Founded in 2018 and based in Munich, LARALAB GmbH is dedicated to advancing interventional cardiology through proprietary deep learning and cloud technology. The company provides fully automated AI-based solutions for transcatheter therapies, including Mitral, Tricuspid, and Aortic Valve procedures. For more information, contact us at contact@laralab.com
About LMU Hospital
The LMU Hospital is one of Germany’s leading university medical centers, renowned for its excellence in cardiovascular medicine and interventional cardiology. The hospital is actively engaged in cutting-edge research and innovation, shaping the future of structural heart disease treatment.
About the Bavarian Research Foundation
The Bavarian Research Foundation (Bayerische Forschungsstiftung) sponsors innovative and application-oriented research and pre-competitive development projects within the Free State of Bavaria.
